Know Which Supplements Promoted During COVID-19 May Be Risky

October 2020

More than 4 in 10 people have increased their use of supplements since the start of the COVID-19 pandemic.

There's still no good evidence ANY supplement helps prevent or treat COVID-19.

Not all supplements are risky. But know which products to advise stopping. And be alert for patients with possible supplement toxicity.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Infectious Diseases Clarify Remdesivir and Convalescent Plasma Use for COVID-19
Acute Care Know When to Add ECG Monitoring With Droperidol
Influenza Use Oseltamivir Over Baloxavir for Hospitalized Flu Patients
Opioids Incorporate Safety Strategies for Long-Acting Opioids
Stroke Don't Jump to Ticagrelor Plus Aspirin After a Minor Stroke
Immunizations Answer Patient Questions About Vaccinations During COVID-19
New Drugs Be Ready to Manage Patients on Palforzia for Peanut Allergy
Med Safety Put Skin Cancer Risk With Hydrochlorothiazide in Perspective
Supplements Know Which Supplements Promoted During COVID-19 May Be Risky
Practice Understand the New Format for Drug Expiration Dates